Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 14, 2017 - Issue 4
Submit an article Journal homepage
164
Views
3
CrossRef citations to date
0
Altmetric
Review

Parachuting: a dangerous trend in recreational psychoactive substance delivery

David BoelsPoison Control Center, Angers University Hospital, Angers, France;EA 4275, SPHERE, Methods for Patients-centered outcomes and Health Research, Nantes University Hospital, Nantes, FranceView further author information
,
Marie Grall-BronnecEA 4275, SPHERE, Methods for Patients-centered outcomes and Health Research, Nantes University Hospital, Nantes, France;Addictology and Psychiatry Department, Nantes University Hospital, Nantes, FranceView further author information
,
Marylène GuerlaisPharmacology Department – Addictovigilance, Nantes University Hospital, Nantes, FranceView further author information
,
Gael Le RouxPoison Control Center, Angers University Hospital, Angers, FranceView further author information
,
Andrew SpiersPharmacology Department – Addictovigilance, Nantes University Hospital, Nantes, FranceView further author information
,
Marie GerardinPharmacology Department – Addictovigilance, Nantes University Hospital, Nantes, FranceView further author information
,
Hélène LomenechPharmacology Department – Addictovigilance, Nantes University Hospital, Nantes, FranceView further author information
,
Marie Bretaudeau-DeguignePoison Control Center, Angers University Hospital, Angers, FranceView further author information
,
Amélie DaveluyPharmacology Department, Bordeaux University Hospital, Bordeaux, FranceView further author information
,
Alain TurcantPharmacology Department – Laboratory, Angers University Hospital, Angers, FranceView further author information
,
Pascale JollietEA 4275, SPHERE, Methods for Patients-centered outcomes and Health Research, Nantes University Hospital, Nantes, France;Pharmacology Department – Addictovigilance, Nantes University Hospital, Nantes, FranceView further author information
&
Caroline Victorri-VigneauEA 4275, SPHERE, Methods for Patients-centered outcomes and Health Research, Nantes University Hospital, Nantes, France;Pharmacology Department – Addictovigilance, Nantes University Hospital, Nantes, FranceCorrespondence[email protected]
View further author information
 show all
Pages 491-498 | Received 18 May 2016, Accepted 02 Aug 2016, Published online: 22 Aug 2016

References

  • Victorri-Vigneau C, Collin C, Messina-Gourlot C, et al. Designing a tool allowing for a standardized assessment of resistance to drug diversion. Expert Opin Drug Deliv. 2014;11(7):995–1004.
  • Daveluy A, Geniaux H, Eiden C, et al. Illicit drugs or medicines taken by parachuting. Fundam Clin Pharmacol. 2016;30(2):185–190.
  • Baumevieille M, Miremont G, Haramburu F, et al. [The French system of evaluation of dependence: establishment in a legal system]. Therapie. 2001;56(1):15–22.
  • Micaleff J, Jolliet P, Victorri-Vigneau C, et al. First meeting of the French CEIP (centres d’evaluation et d’information sur la pharmacodependance). Assessment of the abuse and pharmacodependence potential during drug development. Therapie. 2008;63(1):55–65.
  • Kenerson KL, Lear-Kaul KC. Ingestion of drugs by “parachuting”: a unique drug delivery technique. Am J Forensic Med Pathol. 2012;33(2):173–175.
  • Hendrickson RG, Horowitz BZ, Norton RL, et al. “Parachuting” meth: a novel delivery method for methamphetamine and delayed-onset toxicity from “body stuffing”. Clin Toxicol (Phila). 2006;44(4):379–382.
  • Kwon SK, Lintner CP, Brandt RD, et al. Parachuting of water-extracted dextromethorphan. Clinicol Toxicol. 2010;48:617.
  • Miotto K, Striebel J, Cho AK, et al. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Drug Alcohol Depend. 2013;132(1–2):1–12.
  • Prosser JM, Nelson LS. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol. 2012;8(1):33–42.
  • Schifano F, Albanese A, Fergus S, et al. Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues. Psychopharmacology (Berl). 2011;214(3):593–602.
  • Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, et al. Khat and synthetic cathinones: a review. Arch Toxicol. 2014;88(1):15–45.
  • Winstock AR, Mitcheson LR, Deluca P, et al. Mephedrone, new kid for the chop? Addiction. 2011;106(1):154–161.
  • Zawilska JB, Wojcieszak J. Designer cathinones–an emerging class of novel recreational drugs. Forensic Sci Int. 2013;231(1–3):42–53.
  • Kirkpatrick MG, Johanson CE, de Wit H. Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013;27(3):256–264.
  • Gonzalez R, Bechara A, Martin EM. Executive functions among individuals with methamphetamine or alcohol as drugs of choice: preliminary observations. J Clin Exp Neuropsychol. 2007;29(2):155–159.
  • OFDT Ofddedt. 2014. Available from: http://www.ofdt.fr/BDD/publications/docs/eisxfbv4.pdf.
  • Menza TW, Jameson DR, Hughes JP, et al. Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. BMC Public Health. 2010;10:774.
  • Dunn M, Day C, Bruno R, et al. Sexual and injecting risk behaviours among regular ecstasy users. Addict Behav. 2010;35(2):157–160.
  • Mehta SH, Srikrishnan AK, Noble E, et al. Emergence of cocaine and methamphetamine injection among HIV-positive injection drug users in northern and western India. Drug Alcohol Depend. 2014;135:160–165.
  • Burns MAS. Medical-legal aspects of abused substances: old & new—licit & illicit. Lawyers & Judges Publishing Company, Inc.; Second edition. 2006.
  • Le Roux G, Bruneau C, Lelievre B, et al. Recreational phenethylamine poisonings reported to a French poison control center. Drug Alcohol Depend. 2015;154:46–53.
  • Barceloux D. Amphetamine and methamphetamine. Hoboken (NJ): John Wiley and sons; 2012.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–1012.
  • Gudin J, Levy-Cooperman N, Kopecky EA, et al. Comparing the effect of tampering on the oral pharmacokinetic profiles of two extended-release oxycodone formulations with abuse-deterrent properties. Pain Med. 2015;16(11):2142–2151.
  • Xu X, Gupta A, Al-Ghabeish M, et al. Risk based in vitro performance assessment of extended release abuse deterrent formulations. Int J Pharm. 2016;500(1–2):255–267.
  • Hale ME, Moe D, Bond M, et al. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain. Pain Manag. 2016. [Epub ahead of print]
  • Rahman Z, Yang Y, Korang-Yeboah M, et al. Assessing impact of formulation and process variables on in-vitro performance of directly compressed abuse deterrent formulations. Int J Pharm. 2016;502(1–2):138–150.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.